Ovarian Cancer Current Events | Ovarian Cancer News | 4
|
| Page
4 of
89 |
1776 Results |
|
|
|
Sort By:
Page Views | Date |
Obesity leads to more aggressive ovarian cancer, Cedars-Sinai research shows
Whether or not a woman is obese will likely affect her outcome once she has been diagnosed with ovarian cancer, according to a new study from Cedars-Sinai Medical Center. view more (2006-08-28)
Mayo Clinic reports possible new therapy for patients with platinum-resistant ovarian cancer
Mayo Clinic today reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy. Thirty-three percent of study participants achieved either complete or partial tumor regression from the therapy, which combines flavopiridol and cisplatin. view more (2007-10-24)
Genetic variations in miRNA processing pathway and binding sites help predict ovarian cancer risk
Genetic variations in the micro-RNA (miRNA) processing pathway genes and miRNA binding sites predict a woman's risk for developing ovarian cancer and her prospects for survival. view more (2009-04-20)
Study fuels debate over whether exercise and body size influence ovarian cancer risk
A new study adds fuel to the debate over whether being fat or inactive affects the risk of developing ovarian cancer. view more (2007-09-27)
Removal of ovaries decreases risk of certain cancers for women at high-risk
Women with mutations in the BRCA1 or BRCA2 genes can significantly reduce their risk of certain types of cancer by having their ovaries removed. view more (2006-07-12)
Study pries into ovarian cancer's deadly secrets
A new University of Michigan Medical School study sheds light on cell defects that lead to one common type of ovarian cancer and puts forth a promising new mouse model that already is being used for preclinical drug testing. view more (2007-04-12)
Study provides clues to prevent spread of ovarian cancer
A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease and prolong survival in mice, according to a study by researchers from the University of Chicago Medical Center, but only if the drug is given early in the disease process. view more (2008-03-14)
Controversies Regarding Ovarian Cancer Treatments Addressed
Trials have raised questions on the current management and standard of care for advanced ovarian cancer (AOC). These controversies highlight implications for future clinical research and policy-making, as reviewed in an article published in the International Journal of Gynecological Cancer. view more (2004-11-10)
Experimental Drug Boosts Survival in Recurrent Ovarian Cancer Patients
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently. view more (2007-09-28)
Radical surgery best option for most ovarian cancer patients with cancer in diaphragm
In a retrospective study looking back at a decade of surgeries, Mayo Clinic Cancer Center researchers have determined that surgery to remove metastatic disease from the diaphragm, in conjunction with other procedures to remove the primary diseased tissue in ovarian cancer patients, significantly increases survival rates. view more (2005-10-13)
International Study Suggests Carboplatin Could Be First-line Chemotherapy Drug For Ovarian Cancer
Results of an international study in this week's issue of THE LANCET suggest that the drug carboplatin could become a first-line chemotherapeutic agent for the treatment of ovarian cancer. Carboplatin was found to be less toxic, although it had no overall survival benefit, compared with other drugs assessed in the study. Ovarian cancer is the... view more... (2002-08-14)
Cranberries may improve chemotherapy for ovarian cancer
Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers have found in a laboratory study that will be reported today at the 234th national meeting of the American Chemical Society. view more (2007-08-22)
Genetic testing for breast or ovarian cancer risk may be greatly underutilized
Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers. view more (2009-05-22)
Breast cancer gene increases risk of several cancers in men
A genetic mutation implicated in an increased risk of breast and ovarian cancers also significantly increases the risk of pancreatic and prostate cancers in men, finds research in the Journal of Medical Genetics. view more (2005-09-02)
Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy. view more (2006-01-05)
Ovarian Cancer Screening Not Catching Early Disease
The new study looked at a screening regimen that combines ultrasound and a blood test for CA-125, a marker for women's cancer. view more (2009-04-02)
Breast Cancer Gene Reviewed
PRESS CONFERENCE - 0930 H Thursday 26 September at Cancer Research UK, 44 Lincoln's Inn Fields, London WC2A 3PX, UK; Further information from Cancer Research UK Press Office (see below). A review article in this week's issue of THE LANCET assesses the impact of BRCA1 gene mutations-known to be strongly associated with an increased risk of breast... view more... (2002-09-25)
Mayo Clinic finds aggressive surgery best option for advanced-stage ovarian cancer patients
Mayo Clinic Cancer Center researchers report aggressive surgical removal of as much cancer as possible throughout the abdomen in ovarian cancer patients is the best option for most women. view more (2006-01-10)
Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center. view more (2009-04-20)
New study establishes criteria to detect ovarian cancer in asymptomatic postmenopausal women
Reporting on the largest study of its kind today at the Society of Gynecologic Oncologists 37th Annual Meeting on Women's Cancer, researchers presented new criteria for detecting ovarian cancer malignancy in postmenopausal asymptomatic women, 55 to 74 years old. view more (2006-03-27)
|
|
| Page
4 of
89 |
1776 Results |
|
|
|
Sort By:
Page Views | Date |
|
